205 related articles for article (PubMed ID: 21278152)
21. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
22. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
23. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
[TBL] [Abstract][Full Text] [Related]
24. Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study.
Pérez-Rodríguez A; Pinto JC; Lourés E; Rodríguez-Trillo A; Cuenca JJ; Batlle J; López-Fernández MF
Eur J Haematol; 2011 Nov; 87(5):448-56. PubMed ID: 21668503
[TBL] [Abstract][Full Text] [Related]
25. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
26. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
[TBL] [Abstract][Full Text] [Related]
27. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
[TBL] [Abstract][Full Text] [Related]
28. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
29. Stress and Exposure Time on von Willebrand Factor Degradation.
Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
[TBL] [Abstract][Full Text] [Related]
30. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
[TBL] [Abstract][Full Text] [Related]
31. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
32. Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease.
Loeffelbein F; Funk D; Nakamura L; Zieger B; Grohmann J; Siepe M; Kroll J; Stiller B
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):926-32. PubMed ID: 25228244
[TBL] [Abstract][Full Text] [Related]
33. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
[TBL] [Abstract][Full Text] [Related]
34. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
35. The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass.
Ranger A; Gaspar M; Elkhatteb A; Jackson T; Fox S; Aw TC; Vipond L; Cotterill J; Ghori A; Laffan M; Arachchillage DRJ
Br J Haematol; 2021 Mar; 192(6):1073-1081. PubMed ID: 33278841
[TBL] [Abstract][Full Text] [Related]
36. Acquired von Willebrand Syndrome: An Under-Recognized Cause of Major Bleeding in the Cardiac Intensive Care Unit.
Jones MB; Ramakrishnan K; Alfares FA; Endicott KM; Oldenburg G; Berger JT; Shankar V; Nath DS; Diab YA
World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):711-716. PubMed ID: 27834763
[TBL] [Abstract][Full Text] [Related]
37. In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.
Ver Elst KM; van Vliet HD; Kappers-Klunne MC; Leebeek FW
Thromb Haemost; 2004 Jul; 92(1):67-74. PubMed ID: 15213847
[TBL] [Abstract][Full Text] [Related]
38. Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.
Gebhard C; Maafi F; Stähli BE; Bonnefoy A; Gebhard CE; Nachar W; de Oliveira Moraes AB; Mecteau M; Mihalache-Avram T; Lavoie V; Kernaleguen AE; Shi Y; Busseuil D; Chabot-Blanchet M; Perrault LP; Rhainds D; Rhéaume E; Tardif JC
Thromb Haemost; 2018 Feb; 118(2):288-297. PubMed ID: 29443370
[TBL] [Abstract][Full Text] [Related]
39. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.
Stockschlaeder M; Schneppenheim R; Budde U
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):206-16. PubMed ID: 24448155
[TBL] [Abstract][Full Text] [Related]
40. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
